JAK1 and anaplastic large cell lymphoma: JAK/STAT pathway mutations in BIA-ALCL were first identified by Blombery et al. who performed whole exome sequencing (WES) in two patients, demonstrating pathogenic somatic variants in STAT3 and JAK1.